Centre for Cancer Genomics and Molecular Therapeutics (C2GMT) CSR Project

Centre for Cancer Genomics and Molecular Therapeutics

Objective

• C2GMT aims to revolutionize cancer research and treatment in India by establishing a comprehensive cancer genome database, developing novel drug targets, and creating preclinical organoid models for testing new therapies. This pioneering initiative seeks to address the rising cancer incidence rates in India, enhance early detection, and improve patient-specific treatment options, ultimately leading to a significant reduction in cancer-related suffering and financial burdens on families.

Description

• Establish a cancer genome database specific to the Indian population., Develop innovative drug targets and therapeutic strategies tailored to Indian genetic diversity., Create preclinical organoid models for personalized drug screening and treatment., Conduct genomic sequencing and analysis for various cancer types., Identify biomarkers for early cancer detection and prognosis., Foster collaboration between academia and industry for translational cancer research., Accelerate the development of safe, effective, and affordable anti-cancer therapeutics.

Impact

• C2GMT's groundbreaking efforts will lead to a profound impact on cancer research and treatment in India. By providing India-specific genomic data, it will enable early detection and personalized treatment, reducing the financial and emotional burden on cancer patients and their families. This initiative will not only enhance the quality of life for cancer patients but also strengthen India's representation in the international cancer research community. Furthermore, the development of novel therapies and technologies will position India at the forefront of cancer research, benefitting both society and the scientific community.